LinkedIn

We are pleased to announce CHI’s and the BioPharma Strategy Series’ 5th annual executive forum “Post-Approval Drug Safety Strategies” being held November 8-9, 2010 at the Crowne Plaza Philadelphia Downtown in Philadelphia, PA. Improving products’ clinical safety will increase the industry’s fundamental value proposition to patients, healthcare providers, payors and regulators. The program will focus on pharmacovigilance program implementation and specific strategies and approaches to creating true value from a peri- and post-approval drug safety program. The approach of this conference is not to look at safety in the silos of early-phase safety or post-approval safety but to view safety holistically, across the lifecycle, especially at the transition from approval to broader use in the marketplace. The special, two-day executive forum entitled “Post-Approval Drug Safety Strategies” will tackle many of the pressing issues that executives are facing today. The deadline for speaking proposal submissions is March 12, 2010. For exhibit, partnering and sponsorship information, please contact: Arnold Wolfson,Business Development Manager, BioPharma Strategy Series, Cambridge Healthtech Institute (CHI), T: (+1) 781.972.5431, E: awolfson@healthtech.com For media and association partnerships, please contact: James Prudhomme, Manager, Marketing, Cambridge Healthtech Institute (CHI), T: (+1) 781.972.5486, E: jprudhomme@healthtech.com